FDA — authorised 4 August 1976
- Marketing authorisation holder: CORDEN PHARMA
- Status: approved
🇺🇸 Gleostine in United States
FDA authorised Gleostine on 4 August 1976
Marketing authorisation
Gleostine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Gleostine approved in United States?
Yes. FDA authorised it on 4 August 1976.
Who is the marketing authorisation holder for Gleostine in United States?
CORDEN PHARMA holds the US marketing authorisation.